Home -> Law Blog Directory -> Academic Blogs -> Instapundit.com
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Academic
: Instapundit.comSALLY PIPES: Avastin: The Fatal Move From The FDA. ?On Dec. 17 the Food and Drug Administration i?
By Glenn Reynolds
SALLY PIPES: Avastin: The Fatal Move From The FDA. “On Dec. 17 the Food and Drug Administration is expected to take the radical step of revoking approval for an advanced drug in the treatment of one of the country’s most deadly diseases.” Because it’s too expensive.
Related: Death Panels Begin. “This was about cost-cutting, not medical efficacy as we?ve repeatedly shown. Ironically, at about the same time the FDA was making its decision, the EU ruled to continue recommending Avastin. So, for breast cancer patients, there is more choice in Europe than the US.”
Full post as published by Instapundit.com on December 16, 2010 (boomark / email).
Pet Food Recall and Deaths
Dogs and Cats Sickened by Tainted Menu Food Products
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Military Veterans Benefits, Part 4
Where to get help
Fatal Drug Bust
City of Louisville awards family a $250,000 wrongful death settlement after a police officer shot a 19-year-old boy.
Pet Food Recall
Diamond Pet Food sets up $3.1 million class action fund for substandard dog food.
Food/Supplements
involving food poisoning, food product recalls, false advertising or labeling, vitamin, weight loss and diet supplement issues.
Chinese Drywall
Homeowners Complain of Sulfur Smell, Corroded Pipes
PETCO
Animal Food Distribution Unsanitary, Food Seized
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.

Cancer Drug Linked to Clotting Risk
Panel: Avastin Shouldn't Be Used for Breast Cancer
Panel finds that Avastin Doesnt Benefit Breast Cancer Patients
Cancer Drug May Be Condemned By F.D.A.
Genentech's Move to Restrict Use of Cheaper Avastin Leads to Probe
FDA May Revoke Approval of Breast Cancer Drug, Avastin








